Literature DB >> 28499529

Abnormal Uterine Bleeding: Current Classification and Clinical Management.

Janice L Bacon1.   

Abstract

Abnormal uterine bleeding is now classified and categorized according to the International Federation of Gynecology and Obstetrics classification system: PALM-COEIN. This applies to nongravid women during their reproductive years and allows more clear designation of causes, thus aiding clinical care and future research.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Abnormal uterine bleeding; Heavy menstrual bleeding; Intermenstrual bleeding

Mesh：

Year:  2017        PMID： 28499529     DOI： 10.1016/j.ogc.2017.02.012

Source DB:  PubMed          Journal:  Obstet Gynecol Clin North Am        ISSN： 0889-8545            Impact factor:   2.844


  4 in total

1.  Subclinical Hypothyroidism in Perimenopausal Abnormal Uterine Bleeding Patients.

Authors:  Ali Sebtain; Muhammad Qasim; Abroo Bahadur; Amjad Ali; Kashif A Samin; Moiz Ahmed
Journal:  Cureus       Date:  2022-02-02

2.  The surgical treatment of idiopathic abnormal uterine bleeding: An analysis of 88 000 patients from the French exhaustive national hospital discharge database from 2009 to 2015.

Authors:  Lucie de Léotoing; Gwendoline Chaize; Jérôme Fernandes; Dusan Toth; Philippe Descamps; Gil Dubernard; Thomas Lafon; Ludovic Lamarsalle; Hervé Fernandez
Journal:  PLoS One       Date:  2019-06-11       Impact factor: 3.240

3.  Deep learning model for classifying endometrial lesions.

Authors:  YunZheng Zhang; ZiHao Wang; Jin Zhang; CuiCui Wang; YuShan Wang; Hao Chen; LuHe Shan; JiaNing Huo; JiaHui Gu; Xiaoxin Ma
Journal:  J Transl Med       Date:  2021-01-06       Impact factor: 5.531

4.  Whole-lesion apparent diffusion coefficient (ADC) histogram as a quantitative biomarker to preoperatively differentiate stage IA endometrial carcinoma from benign endometrial lesions.

Authors:  Jieying Zhang; Xiaoduo Yu; Xiaomiao Zhang; Shuang Chen; Yan Song; Lizhi Xie; Yan Chen; Han Ouyang
Journal:  BMC Med Imaging       Date:  2022-08-08       Impact factor: 2.795
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.